Cargando…

Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats

Anxiety disorders are one of the most common mental disorders, and benzodiazepines (BDZs), acting on gamma-aminobutyric acid type A (GABA-A) receptor complex, represent the most common antianxiety medications in the world. However, chronic BDZ use elicits several adverse reactions. Reportedly, aroma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rombolà, Laura, Scuteri, Damiana, Adornetto, Annagrazia, Straface, Marilisa, Sakurada, Tsukasa, Sakurada, Shinobu, Mizoguchi, Hirokazu, Corasaniti, Maria Tiziana, Bagetta, Giacinto, Tonin, Paolo, Morrone, Luigi Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710760/ https://www.ncbi.nlm.nih.gov/pubmed/31485242 http://dx.doi.org/10.1155/2019/2156873

Ejemplares similares

Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues
por: Rombolà, Laura, et al.
Publicado: (2022)

Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent
por: Rombolà, Laura, et al.
Publicado: (2020)

Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach
por: Scuteri, Damiana, et al.
Publicado: (2019)

Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats
por: Rombolà, Laura, et al.
Publicado: (2017)

Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions
por: Scuteri, Damiana, et al.
Publicado: (2022)

Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy
por: Scuteri, Damiana, et al.
Publicado: (2022)

Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia
por: Scuteri, Damiana, et al.
Publicado: (2021)

Efficacy of Essential Oils in Pain: A Systematic Review and Meta-Analysis of Preclinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2021)

Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia
por: Scuteri, Damiana, et al.
Publicado: (2022)

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
por: Scuteri, Damiana, et al.
Publicado: (2019)

Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms
por: Scuteri, Damiana, et al.
Publicado: (2017)

Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation”
por: Scuteri, Damiana, et al.
Publicado: (2021)

Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
por: Rombolà, Laura, et al.
Publicado: (2020)

Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation
por: Hamamura, Kengo, et al.
Publicado: (2020)

Pattern of triptans use: a retrospective prescription study in Calabria, Italy
por: Scuteri, Damiana, et al.
Publicado: (2020)

Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double‐blind, placebo‐controlled trial to assess the efficacy of furocoumarin‐free bergamot loaded in a nanotechnology‐based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia
por: Scuteri, Damiana, et al.
Publicado: (2021)

Opioids Resistance in Chronic Pain Management
por: Morrone, Luigi A., et al.
Publicado: (2017)

Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice
por: Scuteri, Damiana, et al.
Publicado: (2020)

Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020)

Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8
por: Hayashi, Takafumi, et al.
Publicado: (2020)

The Role of Autophagy in Glaucomatous Optic Neuropathy
por: Adornetto, Annagrazia, et al.
Publicado: (2020)

Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis
por: Scuteri, Damiana, et al.
Publicado: (2023)

Role of D-Limonene in Autophagy Induced by Bergamot Essential Oil in SH-SY5Y Neuroblastoma Cells
por: Russo, Rossella, et al.
Publicado: (2014)

Rational Basis for Nutraceuticals in the Treatment of Glaucoma
por: Antonio, Morrone Luigi, et al.
Publicado: (2018)

Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
por: Scuteri, Damiana, et al.
Publicado: (2021)

Effect of Gabapentin in a Neuropathic Pain Model in Mice Overexpressing Human Wild-Type or Human Mutated Torsin A
por: Scuteri, Damiana, et al.
Publicado: (2021)

Exploitation of Thermal Sensitivity and Hyperalgesia in a Mouse Model of Dystonia
por: Scuteri, Damiana, et al.
Publicado: (2021)

Inhibition of Neuromuscular Contractions of Human and Rat Colon by Bergamot Essential Oil and Linalool: Evidence to Support a Therapeutic Action
por: Straface, Marilisa, et al.
Publicado: (2020)

Dementia and COVID-19: A Case Report and Literature Review on Pain Management
por: Scuteri, Damiana, et al.
Publicado: (2022)

Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia
por: Scuteri, Damiana, et al.
Publicado: (2022)

Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis
por: Corasaniti, Maria Tiziana, et al.
Publicado: (2023)

Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis
por: Scuteri, Damiana, et al.
Publicado: (2020)

Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
por: Russo, Rossella, et al.
Publicado: (2015)

Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia
por: Scuteri, Damiana, et al.
Publicado: (2020)

Pain Assessment and Treatment in Dementia at the Time of Coronavirus Disease COVID-19
por: Scuteri, Damiana, et al.
Publicado: (2020)

Impairment of Neuronal Glutamate Uptake and Modulation of the Glutamate Transporter GLT-1 Induced by Retinal Ischemia
por: Russo, Rossella, et al.
Publicado: (2013)

Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat
por: Varano, Giuseppe Pasquale, et al.
Publicado: (2017)

Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy
por: Scuteri, Damiana, et al.
Publicado: (2019)

Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine
por: Scuteri, Damiana, et al.
Publicado: (2022)

Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Corasaniti, Maria Tiziana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u65ab7hh8p6amj5b5ne86jp37t